Clinically Isolated Syndrome
45
9
11
20
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
11.1%
5 terminated out of 45 trials
80.0%
-6.5% vs benchmark
16%
7 trials in Phase 3/4
30%
6 of 20 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 20 completed trials
Clinical Trials (45)
A Study Evaluating B Cell Levels In Infants Potentially Exposed To Ocrelizumab During Pregnancy
Autoimmune Intervention Mastery Course Study
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
Impact of Ocrelizumab on Cerebrospinal Fluid Biomarkers at Multiple Sclerosis Onset
A Study Evaluating B Cell Levels In Infants Of Lactating Women With CIS Or MS Receiving Ocrelizumab
Clinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis: A Trans-regional Digital Health Effort Unlocking the Potential of Artificial Intelligence and Data Science in Health Care
Clinically Isolated Syndrome and Relapsing-Remitting Multiple Sclerosis
Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.
Clinical Impact Through AI-assisted MS Care - A Prospective Multi-center Study
Clinical Monitoring, MRI and Neuro-Ophthalmology of a Cohort of Patients With a Clinically Isolated Syndrome (CIS)
Glymphatic MRI in Clinically Isolated Syndrome
Predictive Value of the Optic Nerve Involvement in Clinically Isolated Syndrome
Visual Processing Speed and Objective Analysis of Ocular Movements in Multiple Sclerosis
Pregnancy Registry, Infants, Serum/Milk Analysis (PRISMA)
Sun Yat-Sen Cohort of CNS Idiopathic Inflammatory Demyelinating Diseases
Study to Assess Changes in Immunoglobulins in Patients With Relapsing Multiple Sclerosis Treated With Anti-CD20 Therapies
A Study to Assess the Effectiveness and Safety of Mayzent in Chinese Patients With Relapsing Forms of Multiple Sclerosis
Tear Analysis by Isoelectric Focusing in Clinically Isolated Syndrome as Multiple Sclerosis Criterion
MS-ResearchBiomarkerS
Understanding Magnetic Resonance Imaging in Multiple Sclerosis